A Phase 3 clinical trial testing benralizumab as a potential treatment in COPD patients has failed to meet its main goal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback